BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 30503404)

  • 1. Clonal analysis revealed functional heterogeneity in cancer stem-like cell phenotypes in uterine endometrioid adenocarcinoma.
    Tabuchi Y; Hirohashi Y; Hashimoto S; Mariya T; Asano T; Ikeo K; Kuroda T; Mizuuchi M; Murai A; Uno S; Kawai N; Kubo T; Nakatsugawa M; Kanaseki T; Tsukahara T; Saito T; Torigoe T
    Exp Mol Pathol; 2019 Feb; 106():78-88. PubMed ID: 30503404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment and Analysis of Cancer Stem-Like and Non-Cancer Stem-Like Clone Cells from the Human Colon Cancer Cell Line SW480.
    Takaya A; Hirohashi Y; Murai A; Morita R; Saijo H; Yamamoto E; Kubo T; Nakatsugawa M; Kanaseki T; Tsukahara T; Tamura Y; Takemasa I; Kondo T; Sato N; Torigoe T
    PLoS One; 2016; 11(7):e0158903. PubMed ID: 27415781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brother of the regulator of the imprinted site (BORIS) variant subfamily 6 is involved in cervical cancer stemness and can be a target of immunotherapy.
    Asano T; Hirohashi Y; Torigoe T; Mariya T; Horibe R; Kuroda T; Tabuchi Y; Saijo H; Yasuda K; Mizuuchi M; Takahashi A; Asanuma H; Hasegawa T; Saito T; Sato N
    Oncotarget; 2016 Mar; 7(10):11223-37. PubMed ID: 26849232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and functional analysis of variants of a cancer/testis antigen LEMD1 in colorectal cancer stem-like cells.
    Takeda R; Hirohashi Y; Shen M; Wang L; Ogawa T; Murai A; Yamamoto E; Kubo T; Nakatsugawa M; Kanaseki T; Tsukahara T; Nishidate T; Okita K; Kutomi G; Sato N; Takemasa I; Torigoe T
    Biochem Biophys Res Commun; 2017 Apr; 485(3):651-657. PubMed ID: 28219643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LY6/PLAUR domain containing 3 has a role in the maintenance of colorectal cancer stem-like cells.
    Wang L; Hirohashi Y; Ogawa T; Shen M; Takeda R; Murai A; Yamamoto E; Kubo T; Nakatsugawa M; Kanaseki T; Tsukahara T; Nishidate T; Okita K; Kutomi G; Sato N; Takemasa I; Torigoe T
    Biochem Biophys Res Commun; 2017 Apr; 486(2):232-238. PubMed ID: 28238780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ectopically expressed variant form of sperm mitochondria-associated cysteine-rich protein augments tumorigenicity of the stem cell population of lung adenocarcinoma cells.
    Takahashi A; Hirohashi Y; Torigoe T; Tamura Y; Tsukahara T; Kanaseki T; Kochin V; Saijo H; Kubo T; Nakatsugawa M; Asanuma H; Hasegawa T; Kondo T; Sato N
    PLoS One; 2013; 8(11):e69095. PubMed ID: 24244262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylation of HSF1 at serine 326 residue is related to the maintenance of gynecologic cancer stem cells through expression of HSP27.
    Yasuda K; Hirohashi Y; Mariya T; Murai A; Tabuchi Y; Kuroda T; Kusumoto H; Takaya A; Yamamoto E; Kubo T; Nakatsugawa M; Kanaseki T; Tsukahara T; Tamura Y; Hirano H; Hasegawa T; Saito T; Sato N; Torigoe T
    Oncotarget; 2017 May; 8(19):31540-31553. PubMed ID: 28415561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MAPK13 is preferentially expressed in gynecological cancer stem cells and has a role in the tumor-initiation.
    Yasuda K; Hirohashi Y; Kuroda T; Takaya A; Kubo T; Kanaseki T; Tsukahara T; Hasegawa T; Saito T; Sato N; Torigoe T
    Biochem Biophys Res Commun; 2016 Apr; 472(4):643-7. PubMed ID: 26969274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian cancer stem cells are enriched in side population and aldehyde dehydrogenase bright overlapping population.
    Yasuda K; Torigoe T; Morita R; Kuroda T; Takahashi A; Matsuzaki J; Kochin V; Asanuma H; Hasegawa T; Saito T; Hirohashi Y; Sato N
    PLoS One; 2013; 8(8):e68187. PubMed ID: 23967051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinase-10 regulates stemness of ovarian cancer stem-like cells by activation of canonical Wnt signaling and can be a target of chemotherapy-resistant ovarian cancer.
    Mariya T; Hirohashi Y; Torigoe T; Tabuchi Y; Asano T; Saijo H; Kuroda T; Yasuda K; Mizuuchi M; Saito T; Sato N
    Oncotarget; 2016 May; 7(18):26806-22. PubMed ID: 27072580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer stem-like cells can be isolated with drug selection in human ovarian cancer cell line SKOV3.
    Ma L; Lai D; Liu T; Cheng W; Guo L
    Acta Biochim Biophys Sin (Shanghai); 2010 Sep; 42(9):593-602. PubMed ID: 20705681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GRIK2 has a role in the maintenance of urothelial carcinoma stem-like cells, and its expression is associated with poorer prognosis.
    Inoue R; Hirohashi Y; Kitamura H; Nishida S; Murai A; Takaya A; Yamamoto E; Matsuki M; Tanaka T; Kubo T; Nakatsugawa M; Kanaseki T; Tsukahara T; Sato N; Masumori N; Torigoe T
    Oncotarget; 2017 Apr; 8(17):28826-28839. PubMed ID: 28418868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small proline-rich protein-1B is overexpressed in human oral squamous cell cancer stem-like cells and is related to their growth through activation of MAP kinase signal.
    Michifuri Y; Hirohashi Y; Torigoe T; Miyazaki A; Fujino J; Tamura Y; Tsukahara T; Kanaseki T; Kobayashi J; Sasaki T; Takahashi A; Nakamori K; Yamaguchi A; Hiratsuka H; Sato N
    Biochem Biophys Res Commun; 2013 Sep; 439(1):96-102. PubMed ID: 23954638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible role of mural cell-covered mature blood vessels in inducing drug resistance in cancer-initiating cells.
    Matsui T; Kinugasa Y; Tahara H; Kanakura Y; Takakura N
    Am J Pathol; 2013 May; 182(5):1790-9. PubMed ID: 23473746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aldehyde Dehydrogenese-1 High Cancer Stem-like Cells/Cancer-initiating Cells Escape from Cytotoxic T Lymphocytes due to Lower Expression of Human Leukocyte Antigen Class 1.
    Shirosaki T; Kawai N; Ebihara Y; Murai A; Kubo T; Morita R; Murata K; Kanaseki T; Tsukahara T; Shichinohe T; Hirohashi Y; Hirano S; Torigoe T
    Anticancer Res; 2024 May; 44(5):1877-1883. PubMed ID: 38677758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GRIK2 is a target for bladder cancer stem-like cell-targeting immunotherapy.
    Miyata H; Hirohashi Y; Yamada S; Yanagawa J; Murai A; Hashimoto S; Tokita S; Hori K; Abe T; Kubo T; Tsukahara T; Kanaseki T; Shinohara N; Torigoe T
    Cancer Immunol Immunother; 2022 Apr; 71(4):795-806. PubMed ID: 34405274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer-initiating cells derived from established cervical cell lines exhibit stem-cell markers and increased radioresistance.
    López J; Poitevin A; Mendoza-Martínez V; Pérez-Plasencia C; García-Carrancá A
    BMC Cancer; 2012 Jan; 12():48. PubMed ID: 22284662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-beta1 promotes the migration and invasion of sphere-forming stem-like cell subpopulations in esophageal cancer.
    Yue D; Zhang Z; Li J; Chen X; Ping Y; Liu S; Shi X; Li L; Wang L; Huang L; Zhang B; Sun Y; Zhang Y
    Exp Cell Res; 2015 Aug; 336(1):141-9. PubMed ID: 26096658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate cancer stem-like cells/cancer-initiating cells have an autocrine system of hepatocyte growth factor.
    Nishida S; Hirohashi Y; Torigoe T; Inoue R; Kitamura H; Tanaka T; Takahashi A; Asanuma H; Masumori N; Tsukamoto T; Sato N
    Cancer Sci; 2013 Apr; 104(4):431-6. PubMed ID: 23320511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblasts induce expression of FGF4 in ovarian cancer stem-like cells/cancer-initiating cells and upregulate their tumor initiation capacity.
    Yasuda K; Torigoe T; Mariya T; Asano T; Kuroda T; Matsuzaki J; Ikeda K; Yamauchi M; Emori M; Asanuma H; Hasegawa T; Saito T; Hirohashi Y; Sato N
    Lab Invest; 2014 Dec; 94(12):1355-69. PubMed ID: 25329002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.